BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dong Y, Li Y, Zhang Y, Zhang T, Zhu L, Dong Y, Wang T. Cefoperazone/sulbactam therapeutic drug monitoring in patients with liver cirrhosis: Potential factors affecting the pharmacokinetic/pharmacodynamic target attainment. Basic Clin Pharmacol Toxicol 2019;125:353-9. [DOI: 10.1111/bcpt.13245] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Li F, Zhou M, Jiao Z, Zou Z, Yu E, He Z. Caspofungin pharmacokinetics and probability of target attainment in ICU patients in China. J Glob Antimicrob Resist 2021;25:238-63. [PMID: 33845162 DOI: 10.1016/j.jgar.2021.03.011] [Reference Citation Analysis]
2 Shi HY, Wang K, Wang RH, Wu YE, Tang BH, Li X, Du B, Kan M, Zheng Y, Xu BP, Shen AD, Su LQ, Jacqz-Aigrain E, Huang X, Zhao W. Developmental population pharmacokinetics-pharmacodynamics and dosing optimization of cefoperazone in children. J Antimicrob Chemother 2020;75:1917-24. [PMID: 32129861 DOI: 10.1093/jac/dkaa071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]